Sanofi

YTD

ALL

Why Robinhood?

You can watch Sanofi and buy or sell other stocks, ETFs, and their options commission-free!

About SNY

Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the Biopharma segment, which comprises commercial operations and research, development and production activities relating to the specialty care, general medicines and vaccines franchises plus support and corporate functions, for all geographical territories.

CEO

Belén Garijo López

CEOBelén Garijo López

Employees

76,493

Employees76,493

Headquarters

Paris, Ile-de-France

HeadquartersParis, Ile-de-France

Founded

1973

Founded1973

Employees

76,493

Employees76,493

SNY Key Statistics

Market cap

98.90B

Market cap98.90B

Price-Earnings ratio

21.37

Price-Earnings ratio21.37

Dividend yield

4.24%

Dividend yield4.24%

Average volume

2.64M

Average volume2.64M

High today

$41.61

High today$41.61

Low today

$40.91

Low today$40.91

Open price

$41.23

Open price$41.23

Volume

3.05M

Volume3.05M

52 Week high

$52.68

52 Week high$52.68

52 Week low

$40.89

52 Week low$40.89

SNY News

TipRanks 2d

Sanofi’s Chinese Pediatric Meningococcal Vaccine Trial Advances, Sharpening Long-Term Growth Prospects for SNY

Sanofi SA (SNY) announced an update on their ongoing clinical study. Sanofi (SNY) is running a Phase 3 trial in China to test an investigational four strain me...

Nasdaq 2d

Sanofi Reviews Pipeline, Broadens Deal Hunt as It Rebuilds Research Engine

Sanofi (NASDAQ:SNY) is reviewing its late-stage pipeline, broadening its business-development lens and working to rebuild early research output under new leader...

TipRanks 6d

Sanofi Targets Teen Acne With New mRNA Vaccine Trial, Opening a Fresh Growth Avenue for SNY

Sanofi SA (SNY) announced an update on their ongoing clinical study. Sanofi SA (SNY) is launching a Phase 1/2 trial called “A Phase 1/2, Randomized, Double-bli...

Analyst ratings

50%

of 8 ratings

Buy

50%

Hold

50%

Sell

More SNY News

TipRanks 6d

Itepekimab COPD Extension Trial Completion: What It Means for Regeneron and Sanofi

Regeneron Pharmaceuticals (REGN), Sanofi (SNYNF) announced an update on their ongoing clinical study. The extension study “A Double-blinded Extension Study to...

Benzinga 7d

Full Transcript: Sanofi Q2 2026 Earnings Call - Benzinga

...

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.